MARKET

IMUX

IMUX

Immunic Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.41
+0.01
+0.16%
Closed 16:00 11/20 EST
OPEN
6.43
PREV CLOSE
6.40
HIGH
7.50
LOW
6.20
VOLUME
50.55K
TURNOVER
--
52 WEEK HIGH
46.80
52 WEEK LOW
6.04
MARKET CAP
64.85M
P/E (TTM)
-1.2222
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of IMUX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

IMUX News

  • Immunic, Inc. Expands Board of Directors with Appointment of Biotechnology Executive Barclay A. Phillips
  • PR Newswire.1d ago
  • Immunic EPS misses by $0.10
  • seekingalpha.11/08 02:58
  • Immunic Q3 EPS $(0.82) May Not Compare To $(0.28) YoY
  • Benzinga.11/07 21:23
  • Immunic, Inc. Reports Third Quarter 2019 Financial Results and Highlights Recent Activity
  • PR Newswire.11/07 21:01

More

Industry

Biotechnology & Medical Research
+0.65%
Pharmaceuticals & Medical Research
-0.14%

Hot Stocks

Name
Price
%Change

About IMUX

Immunic, Inc., formerly Vital Therapies, Inc., is a clinical-stage biopharmaceutical company. The Company is focused on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases. The Company is developing three small molecule products: IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. The Company’s lead development program, IMU-838, is in Phase II clinical development for ulcerative colitis and relapsing-remitting multiple sclerosis, with an additional Phase II trial in Crohn’s disease.
More

Webull offers Immunic Inc (IMUX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.